Samsung Bioepis Co., Ltd. announced today new data supporting consistent efficacy of SB16 (OBODENCE®1), a biosimilar to Prolia2 (denosumab) across patient subgroups compared to the reference denosumab ...
O2 Resort Valle highlights its evolution in Valle de Guadalupe, showcasing its cross-border vision, design-driven hospitality ...
Discusses Launch of ISG AI Index and Trends in Technology Services and Cloud Infrastructure April 16, 2026 9:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results